How to run clinical trials in the Middle East - introduction
This article was originally published in Scrip
Executive Summary
The attractions of the Middle East as a location for clinical research include patient diversity, world-class medical facilities, cost advantages and favourable infrastructure. Indeed multinational CROs think the region is about to experience a surge in clinical trials. Yet there are major discrepancies between countries in terms of adherence to regulations and political stability, reports Faraz Kermani.